Repros' Hypogonadism Treatment Enclomiphene Heads To FDA Panel

Efficacy and safety data for drug, formerly known as Androxal, will be vetted by FDA’s Bone, Reproductive and Urologic Drugs Advisory Committee Nov. 3.